Restricted accessEditorialFirst published online 2016-1
Percutaneous Coronary Intervention Rates and Associated Independent Predictors for Progression of Nontarget Lesions in Patients With Diabetes Mellitus After Drug-Eluting Stent Implantation
GershlickAHKhanJNKellyDJ. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015;65(10):963–972.
2.
WangLZhouYPengP. Percutaneous coronary intervention rates and associated independent predictors for progression of non-target lesions in patients with diabetes mellitus after drug-eluting stent implantation. Angiology. 2015. doi:10.1177/0003319715578565.
3.
BrownAJMcCormickLMGajendragadkarPR. Initial SYNTAX score predicts major adverse cardiac events after primary percutaneous coronary intervention. Angiology. 2014;65(5):408–412.
4.
SahebkarAWattsGF. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes. Clin Ther. 2013;35(8):1082–1098.
5.
De BruyneBPijlsNHKalesanB. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012(11);367:991–1001.
